unick-fix-a-form-and-printersUnick Fix-A-Form And Printers Ltd.

₹65+0.00%

Market Cap

₹0.00 Cr

Stock P/E

0.00

ROCE

0.00%

ROE

0.00%

Book Value

₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Public

Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Unick Fix-A-Form And Printers Ltd. currently exhibits weak financial metrics, with no growth, profitability, or efficiency, leading to an unfavorable comparison with its peers in the Pharmaceuticals & Drugs sector. Companies like Sun Pharmaceutical Industries Ltd. and Dr. Reddy's Laboratories Ltd. stand out as strong performers, showcasing robust profitability and growth, while Unick's lack of revenue and EPS growth marks it as an underperformer in this competitive landscape.

Key Points

• Unick has no revenue or EPS growth, placing it at a disadvantage compared to peers.
• Sun Pharmaceutical and Dr. Reddy's Laboratories are sector leaders with strong profitability and growth metrics.
• Cipla and Mankind Pharma show promising growth with reasonable valuation metrics.

Top Performers

Sun Pharmaceutical Industries Ltd.

Highest profitability metrics with strong revenue and EPS growth.

Dr. Reddy's Laboratories Ltd.

Consistent growth in revenue and EPS, along with strong returns and low debt.

Cipla Ltd.

Good balance of growth and valuation attractiveness.

Mankind Pharma Ltd.

High revenue growth trajectory with solid profitability.

Explore

Watchlists

Command Palette